Committee Testimony and Witness Signup
SB0393 - Health Insurance - Prescription Drug Formularies and Coverage for Generic Drugs and Biosimilars
Finance 2/5/2025 2:00:00 PM
As of: 5/9/2025 2:46:10 PM
| Name | Organization | Position | Testimony | Committee |
|---|---|---|---|---|
| Senator Lam, Senator Lam | FAV |
In Person - Oral Testimony |
FIN | |
| Sharp, David | Maryland Health Care Commission | FAV | 2025 Legislation - MHCC - SB 393 - HI-Prescription | FIN |
| Plante, Cecilia | Maryland Legislative Coalition | FAV | No Testimony | FIN |
| Johnson, Deron | Amgen | UNF | No Testimony | FIN |
| Rush, Jason | FAV | SB0393 Written Testimony.pdf | FIN | |
| Kauffman, Danna | FAV | SB0393_FAV_MedChi_HI - Pres. Drug Formularies & Co | FIN | |
| Harris, Mrs. | INFO | No Testimony | FIN | |
| Celentano, Matthew | The League of Life and Health Insurers of Maryland | UNF |
In Person - Oral Testimony DOCS-#238629-v1-SB_393_League_OPPOSE_2025.DOCX.pdf |
FIN |
| Adams, Chris | SharpRank | FAV |
Virtual - Oral Testimony Testimony for MD SB 393.pdf |
FIN |
| Kamath, Viraj | RareGen Youth Network | FAV |
In Person - Oral Testimony |
FIN |
| Allen, Susan | FAV | No Testimony | FIN | |
| Kirk Robins, Catherine | Maryland Citizens' Health Initiative, Inc. | FAV | MCHI_FAV_SB 393.pdf | FIN |
| Johansen, Michael | RWL | UNF |
In Person - Oral Testimony |
FIN |
| Mauer, William | FAV | No Testimony | FIN | |
| Robinson, Kimberly | CareFirst BlueCross BlueSheild | UNF |
In Person - Oral Testimony |
FIN |
| Grant, Marie | Maryland Insurance Administration | INFO | SB 393 (HB 529) - MIA - LOI - Clean Final .pdf | FIN |
| Testimony, All | N/A | Merged Testimony as of 2-4-2025 at 645 AM | FIN |
Validation
Please fix the following:
MyMGA
Accessibility Tools